59
DAFTAR PUSTAKA
1. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ (Buddy), Culebras A, dkk.
An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
Stroke. 2013;44(7):2064–89.
2. Nicol MB, Thrift AG. Knowledge of risk factors and warning signs of stroke. Vasc Health Risk Manag. 2005;1(2):137–47.
3. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RAL, McNeil JJ, dkk.
Cost of Stroke in Australia From a Societal Perspective: Results From the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001;32(10):2409–16.
4. Writing Group Members, Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, dkk. Heart Disease and Stroke Statistics—2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
Circulation [Internet]. 2006 [dikutip 29 April 2022];113(6). Tersedia pada:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.105.171600
5. Indonesia, Badan Penelitian dan Pengembangan Kesehatan. Riset kesehatan dasar:
riskesdas, 2013. 2013.
6. Soeharto I. Penyakit Jantung Koroner dan Serangan Jantung. Jakarta: Gramedia; 2004.
7. Gorelick PB, Farooq MU. Stroke: an emphasis on guidelines. Lancet Neurol.
2015;14(1):2–3.
8. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, dkk.
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. Januari 1993;24(1):35–41.
9. Lumbantobing SM. Neurogeriatri. Jakarta: Balai Penerbit FKUI; 2004. 90–134 hlm.
10. Chung MK, Eckhardt LL, Chen LY, Ahmed HM, Gopinathannair R, Joglar JA, dkk.
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. Circulation [Internet].
2020 [dikutip 29 April 2022];141(16). Tersedia pada:
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000748
11. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;213.
12. PERKI. Pedoman Tata Laksana Fibrilasi Atrium Nonvalvular. 2 ed. Jakarta: PT. Trans Medical International.; 2019. 1–3 hlm.
13. Maldonado KA, Alsayouri K. Physiology, Brain. Dalam: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2022 [dikutip 30 April 2022]. Tersedia pada: http://www.ncbi.nlm.nih.gov/books/NBK551718/
14. Chayer C, Freedman M. Frontal lobe functions. Curr Neurol Neurosci Rep.
2001;1(6):547–52.
15. Bloom W, Fawcett DW. A textbook of histology. 10th ed. Philadelphia: Saunders;
1975. 1033 hlm.
16. Junaidi I. Panduan Praktis Pencegahan dan Pengobatan Stroke. Jakarta: Buana Ilmu Populer; 2003.
17. Mizrahi EM, Kass JS. Neurology Secrets. Elsevier; 2017.
18. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol. 2003;2(3):177–88.
19. Adams HP, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, dkk. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53(1):126–126.
20. HICKEY JV. Clinical practice of neurological and neurosurgical nursing. St. louis:
Wolters kluwer health; 2014.
21. Brust JCM. Current diagnosis and treatment neurology. New York: McGraw Hill Medical; 2012.
22. Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke.
Int J Stroke Off J Int Stroke Soc. 2012;7(5):378–85.
23. Mardjono M. Neurologi Klinis Dasar. 12 ed. Jakarta: Dian Rakyat; 2008. 489–490 hlm.
24. Cassella CR, Jagoda A. Ischemic Stroke. Emerg Med Clin North Am. 2017;35(4):911–
30.
25. Barreto AD. Intravenous thrombolytics for ischemic stroke. Neurother J Am Soc Exp Neurother. 2011;8(3):388–99.
26. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ (Buddy), Demaerschalk BM, dkk. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
27. Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35(2):520–6.
28. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, dkk. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine.
Stroke. 2003;34(4):975–81.
29. Bernhardt J, Dewey H, Thrift A, Donnan G. Inactive and alone: physical activity within the first 14 days of acute stroke unit care. Stroke. 2004;35(4):1005–9.
30. Wijman CA, Babikian VL, Winter MR, Pochay VE. Distribution of cerebral microembolism in the anterior and middle cerebral arteries. Acta Neurol Scand.
2000;101(2):122–7.
31. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150–61.
32. Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, dkk.
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020;383(3):207–17.
33. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, dkk.
Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study. Stroke. 2003;34(7):1586–92.
34. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, dkk.
Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69(4):619–27.
35. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, dkk.
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2014;45(12):3754–832.
36. Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna J Med. 2016;6(1):8–16.
37. Authors/Task Force Members, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, dkk. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. Eur Heart J. 2006;27(16):1979–2030.
38. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke Off J Int Stroke Soc.
2021;16(2):217–21.
39. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol.
2001;37(2):371–8.
40. Markides V, Schilling RJ. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart Br Card Soc. 2003;89(8):939–43.
41. Issa ZF. Clinical arrhythmology and electrophysiology: a companion to Baunwald’s heart disease. 3rd edition. Philadelphia, MO: Elsevier; 2018.
42. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GYH, Schotten U, dkk. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J.
2010;31(19):2369–429.
43. Lawrence Rosentha. Atrial Fibrillation Clinical Presentation [Internet]. 2013 [dikutip 2 Mei 2022]. Tersedia pada: https://emedicine.medscape.com/article/151066- questions-and-answers
44. Lip GYH, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, dkk.
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/
stenting. Thromb Haemost. 2010;103(1):13–28.
45. Lundström T, Rydén L. Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand. 1988;223(1):53–9.
46. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: natural history, complications, and management. Annu Rev Med. 1988;39:41–52.
47. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476–84.
48. Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36(46):3250–7.
49. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet.
2005;365(9468):1415–28.
50. Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, dkk.
Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study. Heart Rhythm. 2011;8(8):1160–6.
51. Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8(7):405–16.
52. Fox CS. Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring.
JAMA. 2004;291(23):2851.
53. Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor PT, dkk. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors:
cohort study based on longitudinal data from the Framingham Heart Study. BMJ.
2018;361:k1453.
54. Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I, dkk.
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation.
2017;136(17):1588–97.
55. Migdady I, Russman A, Buletko AB. Atrial Fibrillation and Ischemic Stroke: A Clinical Review. Semin Neurol. 2021;41(4):348–64.
56. Gabet A, Guenancia C, Duloquin G, Olié V, Béjot Y. Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry. Stroke. Juni 2021;52(6):2077–85.
57. Kostopoulou A, Zeljko HM, Bogossian H, Ciudin R, Costa F, Heijman J, dkk. Atrial fibrillation-related stroke in women: Evidence and inequalities in epidemiology, mechanisms, clinical presentation, and management. Clin Cardiol. Januari 2020;43(1):14–23.
58. Kim TH, Yang PS, Yu HT, Jang E, Uhm JS, Kim JY, dkk. Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population.
Stroke. Agustus 2018;49(8):1872–9.
59. Tsang TSM, Miyasaka Y, Barnes ME, Gersh BJ. Epidemiological Profile of Atrial Fibrillation: A Contemporary Perspective. Prog Cardiovasc Dis. Juli 2005;48(1):1–8.
60. Patricia H, Kembuan MAHN, Tumboimbela MJ. KARAKTERISTIK PENDERITA STROKE ISKEMIK YANG DI RAWAT INAP DI RSUP PROF. DR. R. D.
KANDOU MANADO TAHUN 2012-2013. E-Clin [Internet]. 23 Januari 2015
[dikutip 10 November 2022];3(1). Tersedia pada:
https://ejournal.unsrat.ac.id/index.php/eclinic/article/view/7402
61. Li J, Zhang P, Liu Y, Chen W, Yi X, Wang C. Stroke Lateralization in Large Hemisphere Infarctions: Characteristics, Stroke-Related Complications, and Outcomes. Front Neurol. 2021;12:774247.
62. Matakas JD, Gold MM, Sterman J, Haramati LB, Allen MT, Labovitz D, dkk. Bovine Arch and Stroke Laterality. J Am Heart Assoc. 7 Juli 2020;9(13):e015390.
63. Inatomi Y, Nakajima M, Yonehara T, Ando Y. Ipsilateral hemiparesis in ischemic stroke patients. Acta Neurol Scand. Juli 2017;136(1):31–40.
64. Yoesdyanto K, Tertia C, Irfani I, Nara MG. LAPORAN KASUS SERI: STROKE KARDIOEMBOLI PADA PASIEN DENGAN ATRIAL FIBRILASI. Callosum Neurol. 25 Februari 2018;1(1):49–69.
65. Skinner NS, Mitchell JH, Wallace AG, Sarnoff SJ. Hemodynamic consequences of atrial fibrillation at constant ventricular rates. Am J Med. Maret 1964;36(3):342–50.
66. Lee SR, Park CS, Choi EK, Ahn HJ, Han KD, Oh S, dkk. Hypertension Burden and the Risk of New-Onset Atrial Fibrillation: A Nationwide Population-Based Study.
Hypertension. 3 Maret 2021;77(3):919–28.
67. Kumar S, Lim E, Covic A, Verhamme P, Gale CP, Camm AJ, dkk. Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation. J Am Coll Cardiol.
Oktober 2019;74(17):2204–15.
68. Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG. Atrial Fibrillation in Ischemic Stroke: Predicting Response to Thrombolysis and Clinical Outcomes. Stroke. Januari 2013;44(1):99–104.
69. Hankey GJ. Potential new risk factors for ischemic stroke: what is their potential?
Stroke. Agustus 2006;37(8):2181–8.
70. Rathfoot C, Edrissi C, Sanders CB, Knisely K, Poupore N, Nathaniel T. Gender differences in comorbidities and risk factors in ischemic stroke patients with a history of atrial fibrillation. BMC Neurol. Desember 2021;21(1):209.
71. Liao X, Ju Y, Liu G, Zhao X, Wang Y, Wang Y. Risk Factors for Pressure Sores in Hospitalized Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. Juli 2019;28(7):2026–30.
72. Weir CJ. The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM. 1 Januari 2003;96(1):67–74.
73. Djurovic O, Mihaljevic O, Radovanovic S, Kostic S, Vukicevic M, Brkic BG, dkk.
Risk Factors Related to Falling in Patients after Stroke. Iran J Public Health [Internet].
5 September 2021 [dikutip 11 November 2022]; Tersedia pada: https://publish.kne- publishing.com/index.php/ijph/article/view/7056
74. Nastiti D. Gambaran faktor risiko kejadian stroke pada pasien stroke rawat inap di RS Krakatau Medika. Universitas Indonesia; 2012.
